Cardiovascular Systems, Inc.

$20.00+0.15%(+$0.03)
TickerSpark Score
67/100
Solid
85
Valuation
55
Profitability
10
Growth
84
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSII research report →

52-Week Range100% of range
Low $12.26
Current $20.00
High $20.00

Companywww.csi360.com

Cardiovascular Systems, Inc. , a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.

CEO
Scott Raymond Ward MS
IPO
2006
Employees
725
HQ
Saint Paul, MN, US

Price Chart

+0.20% · this period
$20.13$16.43$12.74May 02Oct 31May 02

Valuation

Market Cap
$843.96M
P/E
-21.24
P/S
3.57
P/B
3.14
EV/EBITDA
-23.71
Div Yield
0.00%

Profitability

Gross Margin
73.14%
Op Margin
-15.16%
Net Margin
-15.63%
ROE
-14.19%
ROIC
-12.66%

Growth & Income

Revenue
$236.22M · -8.79%
Net Income
$-36,933,000 · -175.19%
EPS
$-0.94 · -168.57%
Op Income
$-35,806,000
FCF YoY
-488.92%

Performance & Tape

52W High
$20.00
52W Low
$12.26
50D MA
$19.84
200D MA
$15.84
Beta
0.74
Avg Volume
677.84K

Get TickerSpark's AI analysis on CSII

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Apr 27, 23Paulsen Eriksell700
Apr 27, 23Paulsen Eriksell20,627
Apr 27, 23Points Jeffrey S.sell138,957
Apr 27, 23Points Jeffrey S.sell34,051
Apr 27, 23Rempe Stephen J.sell75,659
Apr 27, 23Rempe Stephen J.sell8,561
Apr 27, 23Sedo Sandrasell81,881
Apr 27, 23Sedo Sandrasell32,503
Apr 27, 23Aronson Martha Goldbergsell29,816
Apr 27, 23Aronson Martha Goldbergsell12,411

Our CSII Coverage

We haven't published any research on CSII yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate CSII Report →

Similar Companies